In recent months, COVID-19 vaccination in the U.S. has “slowed to a crawl” as an increasingly distrustful public says “no thanks” to primary shots and boosters. Still, U.S. public health agencies continue to authorize, approve and recommend COVID-19 vaccines — even for infants.On Tuesday, advisors to the Centers for Disease Control and Prevention (CDC) — perhaps believing they can reverse the slowdown in “vaccine uptake” and without admitting to the ravages caused by the Pfizer/BioNTech, Moderna and Johnson & Johnson (J&J) shots — unanimously recommended the “Novavax COVID-19 Vaccine, Adjuvanted.”The U.S. Food and Drug Administration (FDA) last week granted Novavax...
